Brian Goff
Fortune : 7 M $ au 30/09/2026
Fortune : 7 M $ au 30/09/2026
Brian M. Goff est membre du conseil d'administration de Pathways to College Network et directeur commercial, directeur des opérations mondiales et vice-président exécutif chez Alexion Pharmaceuticals, Inc. Auparavant, M. Goff a occupé les postes de directeur de l'exploitation et de directeur chez Neurovance, Inc, de responsable de la franchise hémophilie mondiale chez Baxter Healthcare Corp, de vice-président exécutif et de président de l'hématologie chez Baxalta, Inc et de vice-président, responsable des soins primaires et des médicaments établis chez Novartis Pharmaceuticals Corp. M. Goff a obtenu un diplôme de premier cycle au Skidmore College et un MBA à la Wharton School de l'Université de Pennsylvanie.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/06/2026 | 184 508 ( 0,31% ) | 6 M $ | 30/09/2026 | |
| 09/06/2026 | 32 609 ( 0,02% ) | 393 265 $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Directeur Général | 08/08/2022 |
| INTELLIA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 13/06/2024 |
Pathways to College Network | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Directeur des opérations | 21/07/2021 |
| BAXALTA INC | Corporate Officer/Principal | 01/07/2016 |
| IDENIX PHARMACEUTICALS INC | Directeur/Membre du Conseil | 15/05/2012 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Corporate Officer/Principal | - |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops treatments for central nervous system disorders | Directeur des opérations | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and other infectious diseases caused by hepatitis and human immunodeficiency virus | Health Technology |
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops treatments for central nervous system disorders | Commercial Services |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Skidmore College
Skidmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Pathways to College Network | |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national